Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

신경병통증의 선별과 척도화를 위한 한국어 신경병통증설문지 개발: 예비연구Development of Korean Neuropathic Pain Questionnaire Neuropathic Pain Screening and Grading: A Pilot Study

Other Titles
Development of Korean Neuropathic Pain Questionnaire Neuropathic Pain Screening and Grading: A Pilot Study
Authors
윤동주오지영김병조임정근배종석정두신주인수박민수김병준
Issue Date
2012
Publisher
대한신경과학회
Keywords
Korean Neuropathic Pain Questionnaire (KNPQ); Neuropathic pain; Pain assessment; Korean Neuropathic Pain Questionnaire (KNPQ); Neuropathic pain; Pain assessment
Citation
대한신경과학회지, v.30, no.1, pp 15 - 25
Pages
11
Journal Title
대한신경과학회지
Volume
30
Number
1
Start Page
15
End Page
25
URI
https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/15930
ISSN
1225-7044
2288-985X
Abstract
Background: The pain-screening questionnaire is a self-reported description of the intensity and nature of pain. This study aimed to develop the Korean Neuropathic Pain Questionnaire (KNPQ) and to assess its reliability and validity regarding the diagnosis of neuropathic pain. Methods: Four screening tools and two rating scales were translated and modified to develop the preliminary KNPQ. Following a development phase and a pilot study, we generated the final 25-item version of the KNPQ. Each item was rated on a numerical scale of 0–10. The validation procedure was performed in 62 patients with neuropathic pain (21 with central pain and 41 with peripheral pain) and in 34 patients with nonneuropathic pain. The internal consistency between items was assessed to determine the reliability of the KNPQ, and its concurrent validity was determined by evaluating the relationship between the Visual Analogue Scale (VAS) and KNPQ scores. Results: The KNPQ was not influenced by age, sex, or pain duration. The 25-item questionnaire demonstrated high internal consistency. The total score of the KNPQ was correlated with the global pain intensity on a VAS. These items were able to differentiate neuropathic pain from nonneuropathic pain with a sensitivity of 84% and a specificity of 44%(when using a cut-off point of 46). Conclusions: The newly developed KNPQ may be used for the initial screening of neuropathic pain patients. However,it cannot be used to differentiate central neuropathic pain from peripheral neuropathic pain.
Files in This Item
There are no files associated with this item.
Appears in
Collections
College of Medicine > Department of Neurology > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Jeong, Du shin photo

Jeong, Du shin
College of Medicine (Department of Neurology)
Read more

Altmetrics

Total Views & Downloads

BROWSE